Hemogenyx Pharmaceuticals Plc (LON:HEMO)

Hemogenyx Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16	14	27	13	18	42
Market Cap Growth	-47.51%	-47.51%	108.28%	-29.33%	-56.10%	494.04%
Enterprise Value	19	15	27	7	9	40
Last Close Price	3.45	4.05	9.20	5.30	7.50	38.60
PB Ratio	19.11	16.63	9.72	4.00	2.25	47.79
P/TBV Ratio	38.82	33.78	11.51	4.58	2.37	65.81
Debt / Equity Ratio	3.07	3.07	1.06	1.06	0.00	1.86
Quick Ratio	0.14	0.14	1.69	3.40	19.41	1.05
Current Ratio	0.72	0.72	2.93	3.47	20.23	1.08
Return on Equity (ROE)	-309.56%	-309.56%	-222.31%	-69.88%	-112.98%	-795.61%
Return on Assets (ROA)	-65.14%	-65.14%	-61.24%	-44.28%	-30.20%	-72.36%
Return on Capital (ROIC)	-73.03%	-73.03%	-65.22%	-46.57%	-31.63%	-78.78%
Earnings Yield	-34.45%	-39.59%	-24.75%	-30.65%	-27.76%	-4.98%
FCF Yield	-25.47%	-29.26%	-23.02%	-25.72%	-17.77%	-4.71%
Buyback Yield / Dilution	-16.95%	-16.95%	-15.25%	-26.59%	-86.57%	-15.00%

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.